Abstract
AbstractAdenosine A2Areceptors are found on striatal neurones projecting to the external pallidum. KW‐6002 (istradefylline) is a potent and selective antagonist for the adenosine A2Areceptors in the CNS and acts to inhibit the excessive activity of this pathway in the MPTP marmoset model of PD, thus relieving parkinsonism. The objectives of this study were to investigate the regional binding of the novel positron emission tomography tracer [11C]KW‐6002 in the healthy human brain and the rat brain, along with receptor occupancy by cold KW‐6002 at varying doses in human. The highest [11C]KW‐6002 uptake in the rat brain was seen in striatum and lower levels in cortex and cerebellum. Brain [11C]KW‐6002 uptake was well characterized in humans by a two‐tissue compartmental model with a blood volume term, and the ED50of cold KW‐6002 was 0.5 mg in the striatum. Over 90% receptor occupancy was achieved with daily oral doses of greater than 5 mg. In humans, blockable binding was present in all gray matter structures including the cerebellum, which has not been reported to express A2Areceptors. MRS 1745, an A2Breceptor selective antagonist, had no effect on the cerebellar binding of [11C]KW‐6002 in rats, suggesting that this blockable signal is unlikely to result from an affinity for adenosine A2Breceptors. Synapse 62:671–681, 2008. © 2008 Wiley‐Liss, Inc.
References
52
Referenced
57
10.1523/JNEUROSCI.20-15-05848.2000
10.1016/S0006-8993(02)03277-8
10.1016/0169-328X(94)90048-5
10.1212/01.WNL.0000073136.00548.D4
10.1093/brain/awh128
10.1007/BF00168627
10.1038/jcbfm.1993.5
10.1016/S0163-7258(96)00094-0
10.1111/j.1476-5381.1996.tb15561.x
10.1007/s002130050380
10.1016/0169-328X(92)90173-9
10.1111/j.1600-0773.1995.tb00135.x
{'issue': '1', 'key': 'e_1_2_1_14_1', 'first-page': 'S456', 'article-title': 'Radiolabelling of KW‐6002 with [11C] iodomethane for studies of the adenosine A2A receptor in vivo', 'volume': '42', 'author': 'Gillies J', 'year': '1999', 'journal-title': 'J Label Comp Radiopharm'}
/ J Label Comp Radiopharm / Radiolabelling of KW‐6002 with [11C] iodomethane for studies of the adenosine A2A receptor in vivo by Gillies J (1999)10.1212/WNL.52.8.1673
10.1097/00004647-200106000-00002
10.1016/S0014-2999(01)01435-2
10.1212/01.WNL.0000081227.84197.0B
10.1002/syn.1110
10.1046/j.0022-3042.2001.00694.x
10.1016/0014-2999(89)90571-2
10.1212/01.WNL.0000095209.59347.79
10.1016/0028-3908(95)00009-U
10.1002/ana.410430415
10.1097/00001756-199808240-00032
10.1212/01.WNL.0000095219.22086.31
10.1021/jm990421v
10.1046/j.1460-9568.2003.02907.x
10.1007/BF00168448
10.1016/0306-4522(91)90038-P
10.1016/S0165-0173(99)00059-4
10.1212/01.WNL.0000095211.71092.A0
10.1523/JNEUROSCI.16-02-00605.1996
10.1016/S0026-895X(25)09820-7
/ Mol Pharmacol / Binding of [3H]KF17837S, a selective adenosine A2A receptor antagonist, to rat brain membranes by Nonaka H (1994){'key': 'e_1_2_1_35_1', 'series-title': 'Biochemical characterization of KW‐6002, a novel potent adenosine A2A receptor antagonist', 'first-page': '937', 'author': 'Nonaka H', 'year': '2001'}
/ Biochemical characterization of KW‐6002, a novel potent adenosine A2A receptor antagonist by Nonaka H (2001)10.1016/S0306-4522(00)00250-5
10.1016/S0165-6147(96)80010-1
/ Trends Pharmac Sci / Pharmacology of adenosine A2A receptors by Ongini E (1996)10.1111/j.1749-6632.1997.tb48412.x
{'volume-title': 'Maps and guide to microdissection of the rat brain', 'year': '1988', 'author': 'Palkovits M', 'key': 'e_1_2_1_39_1'}
/ Maps and guide to microdissection of the rat brain by Palkovits M (1988)10.1046/j.1471-4159.1996.66010362.x
{'key': 'e_1_2_1_41_1', 'first-page': '259', 'article-title': 'The on‐line monitoring of continuously withdrawn arterial blood during PET studies using a single bgo/photomultiplier assembly and non‐stick tubing', 'volume': '17', 'author': 'Ranicar AS', 'year': '1991', 'journal-title': 'Med Prog Technol'}
/ Med Prog Technol / The on‐line monitoring of continuously withdrawn arterial blood during PET studies using a single bgo/photomultiplier assembly and non‐stick tubing by Ranicar AS (1991)10.1016/S0165-6147(97)90660-X
/ Trends Pharmacol / Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease by Richardson PJ (1997)10.1002/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D
10.1016/0304-3940(91)90391-6
10.1016/0301-0082(95)00035-6
10.1016/S0960-894X(97)00440-X
10.1111/j.1469-7793.2001.0423f.x
10.1016/j.neulet.2003.08.059
10.1088/0031-9155/45/9/313
10.1118/1.598130
10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E
10.1212/01.WNL.0000095221.30476.8A
10.1212/01.WNL.0000095220.87550.F6
Dates
Type | When |
---|---|
Created | 17 years, 2 months ago (June 24, 2008, 1:53 p.m.) |
Deposited | 7 months ago (Jan. 30, 2025, 4:07 p.m.) |
Indexed | 7 months ago (Jan. 30, 2025, 4:40 p.m.) |
Issued | 17 years, 2 months ago (June 24, 2008) |
Published | 17 years, 2 months ago (June 24, 2008) |
Published Online | 17 years, 2 months ago (June 24, 2008) |
Published Print | 16 years, 11 months ago (Sept. 1, 2008) |
@article{Brooks_2008, title={Positron emission tomography analysis of [11C]KW‐6002 binding to human and rat adenosine A2Areceptors in the brain}, volume={62}, ISSN={1098-2396}, url={http://dx.doi.org/10.1002/syn.20539}, DOI={10.1002/syn.20539}, number={9}, journal={Synapse}, publisher={Wiley}, author={Brooks, D.J. and Doder, M. and Osman, S. and Luthra, S.K. and Hirani, E. and Hume, S. and Kase, H. and Kilborn, J. and Martindill, S. and Mori, A.}, year={2008}, month=jun, pages={671–681} }